The 3D-printed blood vessels are customizable per the particular patient and have potential to replace damaged blood vessels in patients with heart disease.
The vessels are created by a printing nozzle that forms tubes with distinct layers filled with ink made from human cells injected into a jelly-like substance. After the printing, the cells multiply until fully formed.
The research team hopes the printed blood vessels can be used to test the safety and efficacy of drugs.
“We’re [interested in] developing technology that can allow us to generate in vitro models of human vessels,” Yu Shrike Zhang, PhD, an associate bioengineer in Brigham’s department of medicine, told STAT.
More articles on clinical leadership and infection control:
Hospital privacy curtains are breeding MRSA, study finds
Mass General physician: Pollution is healthcare’s hidden harm
US News medical school rankings have little effect on patient outcomes, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
